• Angiotensin Converting Enzyme (ACE), CSF
  • Enterovirus, Real-time PCR, CSF
  • Coagulation Factor VIII Inhibitor Screen, Plasma
  • Antimicrobial Susceptibility (AST) Testing with Minimum Inhibitory Concentration (MIC)
  • Mumps Virus Antibody, IgM
  • JAK2 Gene Mutation (Exons 12-15 or full sequencing) Analysis
  • Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), Random, Urine
  • B-Cell Acute Lymphoblastic Leukemia (ALL), FISH, Bone Marrow
  • Schistosomiasis
  • ADAMTS13 Activity and Inhibitor Assay
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Interpretation
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.